High Court's Pass Gives Drug-Patent Safe Harbor Wide Reach
The U.S. Supreme Court's Monday rejection of an appeal by Momenta Pharmaceuticals Inc. over the Hatch-Waxman Act safe harbor, which protects some infringing conduct involving drug patents, leaves intact a broad...To view the full article, register now.
Already a subscriber? Click here to view full article